Financials
- Market Capitalization 1.66 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.15
Relación precio/flujo de caja
170.48
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2037 | ZBIO Zenas BioPharma, Inc. - Common Stock | 27.26 USD | 0.00% | -3.54% | -12.06% | +3.02% | 1.78 B USD | ||
| 2047 | NUVB Nuvation Bio Inc. Class A Common Stock | 4.90 USD | -2.00% | -1.21% | -16.95% | +29.29% | 1.72 B USD | ||
| 2092 | OCUL Ocular Therapeutix, Inc. - Common Stock | 7.66 USD | +1.59% | +9.27% | -27.80% | -33.39% | 1.68 B USD | ||
| 2121 | STOK Stoke Therapeutics, Inc. - Common Stock | 24.39 USD | -1.41% | -2.48% | -16.98% | -19.18% | 1.57 B USD |